国产精品视频一区二区三区四,亚洲av美洲av综合av,99国内精品久久久久久久,欧美电影一区二区三区电影

重組人內(nèi)分泌腺血管內(nèi)皮生長因子（rHuEG-VEGF）返回列表頁

舉報(bào) 評(píng)價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)經(jīng)銷商

所在地上海市

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-05-02 12:23:15瀏覽次數(shù)：866次

聯(lián)系我時(shí)，請(qǐng)告知來自化工儀器網(wǎng)

產(chǎn)品分類品牌分類

以色列Prospec細(xì)胞因子

全部產(chǎn)品列表

產(chǎn)品簡(jiǎn)介

佰易聚生物商城提供美國光譜醫(yī)學(xué)透析袋，wako生化試劑，amresco生化試劑，sigma生化試劑，優(yōu)質(zhì)的分子生物學(xué)試劑和試劑盒、培養(yǎng)基本和培養(yǎng)耗材、細(xì)胞因子和細(xì)胞分離液、抗體和elisa試劑盒及常用生物試劑等,大量現(xiàn)貨火爆*,歡迎登錄 www.ebioeasy.com或者,，洽談選購！

詳情介紹

CYT-338

重組人內(nèi)分泌腺血管內(nèi)皮生長因子（rHuEG-VEGF）

2μg/10μg/1mg

Prospec

Background:
	Human endocrine gland derived vascular endothelial growth factor （EG-VEGF） is selectively expressed in steroidogenic glands and promotes growth of endocrine gland endothelium. The identification of tissue-selective angiogenic factors raises the possibility that other secreted molecules in this class exist. Consistent with such an expression pattern, the human EG-VEGF gene promoter has a potential binding site for steroidogenic factor （SF）-1, a pivotal element for steroidogenic-specific transcription. In the human ovary, the expression of EG-VEGF is temporally and spatially complementary to the expression of VEGF-A, both in the follicular and in the luteal phase, suggesting complementary and coordinated roles of these molecules in ovarian angiogenesis. Also, EG-VEGF expression correlates with vascularity in the polycystic ovary syndrome, a leading cause of infertility.
	Description :
	Recombinant Human EG-VEGF produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 86 amino acids and having a molecular mass of 9605 Dalton. Recombinant EG-VEGF is purified by proprietary techniques.
	Physical Appearance:
	Sterile Filtered White lyophilized （freeze-dried） powder.
	Formulation:
	Recombinant VEGF was lyophilized from a concentrated （1mg/ml） solution with no additives.
	Solubility:
	It is recommended to reconstitute the lyophilized VEGF in sterile 18M-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
	Stability:
	Lyophilized VEGF although stable at room temperature for 3 weeks, should be stored desiccated below -18 C. Upon reconstitution rHuVEGF should be stored at 4 C between 2-7 days and for future use below -18 C. For long term storage it is recommended to add a carrier protein （0.1% HSA or BSA）. Please prevent freeze-thaw cycles.
	Purity:
	Greater than 98.0% as determined by: （a） Analysis by RP-HPLC. （b） Anion-exchange FPLC. （c） Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
	Amino acid sequence:
	The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Ile-Thr-Gly.
	Dimers and aggregates:
	Less than 1% as determined by silver-stained SDS-PAGE gel analysis.
	Biological Activity:
	The biological activity is determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells （HUVEC） using a concentration range of 1.0-5.0 ng/ml.
	Endotoxin:
	Less than 0.1 ng/µg （IEU/µg） of EG-VEGF.
	Protein content:
	Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280 nm. 2. Analysis by RP-HPLC, using a calibrated solution of EG-VEGF as a Reference Standard.
	Usage:
	Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.